Evaluation of the Effect of Propolis Supplement on Women with Polycystic Ovary Syndrome

Phase 2

Conditions: Polycystic Ovary Syndrome.
Polycystic ovarian syndrome
E28.2

Registration Number: IRCT20200912048693N1

Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Female

Target Recruitment: 70

Inclusion Criteria

Having Polycystic ovary syndrome according to Rotterdam criteria
Body mass index (BMI) greater than or equal to 18.5 kg/m2

Exclusion Criteria

Pregnancy
Lactation
Insulin injection
People with autoimmune diseases
People with gastrointestinal diseases
People with liver disease
People with thyroid disease
People with cardiovascular disease
People with severe respiratory illness such as asthma and chronic bronchitis
Consume any vitamins, minerals and dietary supplements
Existence of allergies to Propolis, Honey and bee products

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
High-sensitivity C-reactive Protein. Timepoint: At the beginning of the study (before the intervention) and at the end of the study. Method of measurement: Enzyme-Linked Immunosorbent Assay.;Insulin Resistance Index. Timepoint: At the beginning of the study (before the intervention) and at the end of the study. Method of measurement: HOMA-IR={[Fasting insulin (microunits/ml)] × [Fasting Glucose (mmol/l)]}/22.5.;Free androgen index. Timepoint: At the beginning of the study (before the intervention) and at the end of the study. Method of measurement: Free androgen index = 100 X [(Total Testosterone)/Sex hormone binding globulin].

Secondary Outcome Measures